Catherine Zhang

机构：University of California, Los Angeles, AbbVie (United States), AbbVie (Japan)

发表论文 68 篇 · 总被引 1001 次 · h-index 13

代表论文

• Development of compact transcriptional effectors using high-throughput measurements in diverse contexts (2024 · Nature Biotechnology · 被引 40)
• Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance (2024 · Immunity · 被引 31)
• Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity (2025 · Journal of Hematology & Oncology · 被引 21)
• Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety (2025 · Molecular Therapy · 被引 20)
• Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells (2025 · Cell Reports Medicine · 被引 16)
• RadImageGAN – A Multi-modal Dataset-Scale Generative AI for Medical Imaging (2025 · Lecture notes in computer science · 被引 6)